Correction to: BMC Emerg Med 20, 56 (2020)

https://doi.org/10.1186/s12873-020-00351-w

The Tokushukai Group Ethical Committee approved that our study had added patients with standard BCAA for a control group to patients with leucine enriched BCAA and additional opt-out consent of patients in the control group is obtained (TGE01445-024).